Multidimensional profiling of plasma lipoproteins by size exclusion chromatography followed by reverse-phase protein arrays

被引:11
|
作者
Dernick, Gregor [1 ]
Obermueller, Stefan [1 ]
Mangold, Cyrill [1 ]
Magg, Christine [1 ]
Matile, Hugues [1 ]
Gutmann, Oliver [1 ]
von der Mark, Elisabeth [2 ]
Handschin, Corinne [2 ]
Maugeais, Cyrille [2 ]
Niesor, Eric J. [2 ]
机构
[1] F Hoffmann La Roche Ltd, Discovery Technol, Basel, Switzerland
[2] F Hoffmann La Roche Ltd, Metab & Vasc Dis, Basel, Switzerland
关键词
HDL proteomics; protein-protein interaction; protein-lipid interaction; fast protein liquid chromatography; size exclusion chromatography; reverse-phase arrays; HIGH-DENSITY-LIPOPROTEIN; PRE-BETA; APOLIPOPROTEIN-E; CHOLESTEROL; PROTEOMICS; METABOLISM; FPLC;
D O I
10.1194/jlr.D016824
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The composition of lipoproteins and the association of proteins with various particles are of much interest in the context of cardiovascular disease. Here, we describe a technique for the multidimensional analysis of lipoproteins and their associated apolipoproteins. Plasma is separated by size exclusion chromatography (SEC), and fractions are analyzed by reverse-phase arrays. SEC fractions are spotted on nitrocellulose slides and incubated with different antibodies against individual apolipoproteins or antibodies against various apolipoproteins. In this way, tens of analytes can be measured simultaneously in 100 mu l of plasma from a single SEC separation. This methodology is particularly suited to simultaneous analysis of multiple proteins that may change their distribution to lipoproteins or alter their conformation, depending on factors that influence circulating lipoprotein size or composition. We observed changes in the distribution of exchangeable apolipoproteins following addition of recombinant apolipoproteins or interaction with exogenous compounds. While the cholesteryl ester transfer protein (CETP)-dependent formation of pre-beta-HDL was inhibited by the CETP inhibitors torcetrapib and anacetrapib, it was not reduced by the CETP modulator dalcetrapib. This finding was elucidated using this technique.-Dernick, G., S. Obermuller, C. Mangold, C. Magg, H. Matile, O. Gutmann, E. von der Mark, C. Handschin, C. Maugeais, and E. J. Niesor. Multidimensional profiling of plasma lipoproteins by size exclusion chromatography followed by reverse-phase protein arrays. J. Lipid Res. 2011. 52: 2323-2331.
引用
收藏
页码:2323 / 2331
页数:9
相关论文
共 50 条
  • [41] Preparation and quantification of methylglyoxal in human plasma using reverse-phase high-performance liquid chromatography
    Nemet, I
    Varga-Defterdarovic, L
    Turk, Z
    CLINICAL BIOCHEMISTRY, 2004, 37 (10) : 875 - 881
  • [42] SIZE EXCLUSION, REVERSE PHASE AND WEAK ANION-EXCHANGE CHROMATOGRAPHY OF NATURAL ORGANICS IN WATER
    GLAZE, WH
    JONES, PC
    SALEH, FY
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1980, 180 (AUG): : 107 - ENVR
  • [43] The Critical Role of Mobile Phase Composition in Size Exclusion Chromatography of Protein Pharmaceuticals
    Arakawa, Tsutomu
    Ejima, Daisuke
    Li, Tiansheng
    Phil, John S.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (04) : 1674 - 1692
  • [44] Proteomic analysis optimization: Selective protein sample on-column retention in reverse-phase liquid chromatography
    Winnik, Witold M.
    Ortiz, Pedro A.
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2008, 875 (02): : 478 - 486
  • [45] Influence of Net Protein Charge and Stationary Phase Charge on Protein Retention in Size Exclusion Chromatography
    Romano, V. A.
    Ebeyer, T.
    Dubin, P. L.
    ACS Symposium Series, (635):
  • [46] Influence of net protein charge and stationary phase charge on protein retention in size exclusion chromatography
    Romano, VA
    Ebeyer, T
    Dubin, PL
    STRATEGIES IN SIZE EXCLUSION CHROMATOGRAPHY, 1996, 635 : 88 - 102
  • [47] Analysis of the metabolic proteome of lung adenocarcinomas by reverse-phase protein arrays (RPPA) emphasizes mitochondria as targets for therapy
    Torresano, Laura
    Santacatterina, Fulvio
    Dominguez-Zorita, Sonia
    Nuevo-Tapioles, Cristina
    Nunez-Salgado, Alfonso
    Esparza-Molto, Pau B.
    Gonzalez-Llorente, Lucia
    Romero-Carraminana, Ines
    Nunez de Arenas, Cristina
    Sanchez-Garrido, Brenda
    Najera, Laura
    Salas, Clara
    Provencio, Mariano
    Cuezva, Jose M.
    ONCOGENESIS, 2022, 11 (01)
  • [48] Analysis of the metabolic proteome of lung adenocarcinomas by reverse-phase protein arrays (RPPA) emphasizes mitochondria as targets for therapy
    Laura Torresano
    Fulvio Santacatterina
    Sonia Domínguez-Zorita
    Cristina Nuevo-Tapioles
    Alfonso Núñez-Salgado
    Pau B. Esparza-Moltó
    Lucía González-Llorente
    Inés Romero-Carramiñana
    Cristina Núñez de Arenas
    Brenda Sánchez-Garrido
    Laura Nájera
    Clara Salas
    Mariano Provencio
    José M. Cuezva
    Oncogenesis, 11
  • [49] Using reverse-phase protein arrays as pharmacodynamic assays for functional proteomics, biomarker discovery, and drug development in cancer
    Lu, Yiling
    Ling, Shiyun
    Hegde, Apurva M.
    Byers, Lauren A.
    Coombes, Kevin
    Mills, Gordon B.
    Akbani, Rehan
    SEMINARS IN ONCOLOGY, 2016, 43 (04) : 476 - 483
  • [50] Reverse-Phase Protein Array for Proteo-Epigenomic Profiling of Colorectal Cancer Patient-Derived Organoids
    Takeda, Shota
    Shiokawa, Taisuke
    Aoyama, Toru
    Yoshioka, Kenichi
    Okamoto, Koji
    Masuda, Mari
    CANCER SCIENCE, 2024, 115 : 488 - 488